Literature DB >> 12009220

Elevations in procalcitonin but not C-reactive protein are associated with pneumonia after cardiopulmonary resuscitation.

Michael Oppert1, Albrecht Reinicke, Christian Müller, Detlev Barckow, Ulrich Frei, Kai-Uwe Eckardt.   

Abstract

A possible diagnostic role of procalcitonin (PCT) as a marker for ventilator associated pneumonia (VAP) in patients with an already triggered acute phase response after successful cardiopulmonary resuscitation (CPR) was investigated. In 28 patients with return of spontaneous circulation (ROSC) after out of hospital CPR, measurements of PCT, C-reactive protein (CrP), white blood cell count (WBC) and body temperature were compared with the clinical course of the patients. In this setting, PCT was the only marker to differentiate between patients with and without VAP (median value on day 1, 6.0 vs. 0.5 ng/ml; P<0.001). Using a cut off value of 1 ng/ml during the first 7 days after ROSC PCT had a sensitivity of 100% and a specificity of 75% to indicate VAP. PCT was elevated a median of 2 days earlier than the clinical diagnosis of VAP. Elevations in PCT can, therefore, indicate bacterial complications in cardiac arrest patients with a non-infectious acute phase response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12009220     DOI: 10.1016/s0300-9572(02)00008-4

Source DB:  PubMed          Journal:  Resuscitation        ISSN: 0300-9572            Impact factor:   5.262


  22 in total

1.  Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society.

Authors:  Andre C Kalil; Mark L Metersky; Michael Klompas; John Muscedere; Daniel A Sweeney; Lucy B Palmer; Lena M Napolitano; Naomi P O'Grady; John G Bartlett; Jordi Carratalà; Ali A El Solh; Santiago Ewig; Paul D Fey; Thomas M File; Marcos I Restrepo; Jason A Roberts; Grant W Waterer; Peggy Cruse; Shandra L Knight; Jan L Brozek
Journal:  Clin Infect Dis       Date:  2016-07-14       Impact factor: 9.079

2.  Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.

Authors:  Boris Jung; Nathalie Embriaco; François Roux; Jean-Marie Forel; Didier Demory; Jérôme Allardet-Servent; Samir Jaber; Bernard La Scola; Laurent Papazian
Journal:  Intensive Care Med       Date:  2010-03-09       Impact factor: 17.440

Review 3.  Biomarkers for ventilator-associated pneumonia: review of the literature.

Authors:  Steven J Palazzo; Terri Simpson; Lynn Schnapp
Journal:  Heart Lung       Date:  2011-03-21       Impact factor: 2.210

4.  Procalcitonin and pneumonia: is it a useful marker?

Authors:  Mirjam Christ-Crain; Beat Müller
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

5.  Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ.

Authors:  Stefan Krüger; Santiago Ewig; Jana Papassotiriou; Jan Kunde; Reinhard Marre; Heike von Baum; Norbert Suttor; Tobias Welte
Journal:  Respir Res       Date:  2009-07-12

6.  Value of procalcitonin for diagnosis of early onset pneumonia in hypothermia-treated cardiac arrest patients.

Authors:  Nicolas Mongardon; Virginie Lemiale; Sébastien Perbet; Florence Dumas; Stéphane Legriel; Sylvie Guérin; Julien Charpentier; Jean-Daniel Chiche; Jean-Paul Mira; Alain Cariou
Journal:  Intensive Care Med       Date:  2009-10-21       Impact factor: 17.440

7.  Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia.

Authors:  Charles-Edouard Luyt; Alain Combes; Catherine Reynaud; Guillaume Hekimian; Ania Nieszkowska; Marc Tonnellier; Alexandra Aubry; Jean-Louis Trouillet; Maguy Bernard; Jean Chastre
Journal:  Intensive Care Med       Date:  2008-04-18       Impact factor: 17.440

8.  Comparison of the predictability of neurological outcome by serum procalcitonin and glial fibrillary acidic protein in postcardiac-arrest patients.

Authors:  Hiromi Hayashida; Tadashi Kaneko; Shunji Kasaoka; Chiyomi Oshima; Takashi Miyauchi; Motoki Fujita; Yasutaka Oda; Ryosuke Tsuruta; Tsuyoshi Maekawa
Journal:  Neurocrit Care       Date:  2010-04       Impact factor: 3.210

Review 9.  Long Noncoding RNA: Regulatory Mechanisms and Therapeutic Potential in Sepsis.

Authors:  Wei Wang; Ni Yang; Ri Wen; Chun-Feng Liu; Tie-Ning Zhang
Journal:  Front Cell Infect Microbiol       Date:  2021-05-12       Impact factor: 5.293

Review 10.  Biomarkers: a definite plus in pneumonia.

Authors:  Hanssa Summah; Jie-Ming Qu
Journal:  Mediators Inflamm       Date:  2009       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.